PRODUCT DETAIL

Valkubit 97 mg/103 mg filmom obalené tablety

Code

3060F

MA number

41/0097/26-S

Product Form:

tbl flm 196x97 mg/103 mg (blis.OPA/Al/PVC/Al-kalend.bal.)

MA Status:

R - Valid Marketing Authorisation

Type of procedure:

Decentralised

MAH, country:

KRKA, d.d., Novo mesto, Slovenia

Therapeutic Class:

41 - CARDIACA

ATC:

C	CARDIOVASCULAR SYSTEM
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09D	ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
C09DX	Angiotensin II receptor blockers (ARBs), other combinations
C09DX04	Valsartan and sacubitril

Shelf life:

Container:

blister OPA/Al/PVC/Al

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	30.03.2026
Validity:	30.03.2031
Pediatric indication:	Yes
Pediatric posology:	Yes
Pediatric warnings:	Yes
PIL:	PIL_Valkubit 24 mg_26 mg; 49 mg_51 mg; 97 mg_103 mg filmom obalené tablety_03.2026.pdf
SPC:	SPC_Valkubit 24 mg_26 mg; 49 mg_51 mg; 97 mg_103 mg filmom obalené tablety_03.2026.pdf
Safety feature	Yes
Data update:	02.04.2026